2m 2m 2m 2m 2m 2m 2m
KYVERNA THERAP (KYTX)
NASDAQ
$8.43+$0.009 (+0.11%)
Price as of Aug 21, 2026 7:53 PM EDT- $520.7MMarket Cap
- 118.70%1-Year Change
- BiotechnologyIndustry
KYVERNA THERAP (KYTX)
$8.43+$0.009 (+0.11%)
KYTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.42 | ||
Change | +$0.29 (+3.57%) | ||
Open | $8.24 | ||
High | $8.58 | ||
Low | $8.19 | ||
Previous Close | $8.13 | ||
Volume | 663,612 | ||
30-Day Average Volume | 756,899 | ||
1-Week Change | 3.06% | ||
1-Month Change | 12.57% | ||
1-Year Change | 118.70% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 61.8M | ||
Total Assets | $219.8M | ||
Market Cap | $520.7M | ||
Enterprise Value | $513.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.3M | ||
Free Cash Flow | -$40.3M | ||
EBIT | -$37.6M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $183.7M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -13 | ||
PEG | -3 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue